TY - JOUR
T1 - Characterization and structural basis of a lethal mouse-adapted SARS-CoV-2
AU - Sun, Shihui
AU - Gu, Hongjing
AU - Cao, Lei
AU - Chen, Qi
AU - Ye, Qing
AU - Yang, Guan
AU - Li, Rui Ting
AU - Fan, Hang
AU - Deng, Yong Qiang
AU - Song, Xiaopeng
AU - Qi, Yini
AU - Li, Min
AU - Lan, Jun
AU - Feng, Rui
AU - Guo, Yan
AU - Zhu, Na
AU - Qin, Si
AU - Wang, Lei
AU - Zhang, Yi Fei
AU - Zhou, Chao
AU - Zhao, Lingna
AU - Chen, Yuehong
AU - Shen, Meng
AU - Cui, Yujun
AU - Yang, Xiao
AU - Wang, Xinquan
AU - Tan, Wenjie
AU - Wang, Hui
AU - Wang, Xiangxi
AU - Qin, Cheng Feng
N1 - Publisher Copyright:
© 2021, The Author(s).
PY - 2021/12/1
Y1 - 2021/12/1
N2 - There is an urgent need for animal models to study SARS-CoV-2 pathogenicity. Here, we generate and characterize a novel mouse-adapted SARS-CoV-2 strain, MASCp36, that causes severe respiratory symptoms, and mortality. Our model exhibits age- and gender-related mortality akin to severe COVID-19. Deep sequencing identified three amino acid substitutions, N501Y, Q493H, and K417N, at the receptor binding domain (RBD) of MASCp36, during in vivo passaging. All three RBD mutations significantly enhance binding affinity to its endogenous receptor, ACE2. Cryo-electron microscopy analysis of human ACE2 (hACE2), or mouse ACE2 (mACE2), in complex with the RBD of MASCp36, at 3.1 to 3.7 Å resolution, reveals the molecular basis for the receptor-binding switch. N501Y and Q493H enhance the binding affinity to hACE2, whereas triple mutations at N501Y/Q493H/K417N decrease affinity and reduce infectivity of MASCp36. Our study provides a platform for studying SARS-CoV-2 pathogenesis, and unveils the molecular mechanism for its rapid adaptation and evolution.
AB - There is an urgent need for animal models to study SARS-CoV-2 pathogenicity. Here, we generate and characterize a novel mouse-adapted SARS-CoV-2 strain, MASCp36, that causes severe respiratory symptoms, and mortality. Our model exhibits age- and gender-related mortality akin to severe COVID-19. Deep sequencing identified three amino acid substitutions, N501Y, Q493H, and K417N, at the receptor binding domain (RBD) of MASCp36, during in vivo passaging. All three RBD mutations significantly enhance binding affinity to its endogenous receptor, ACE2. Cryo-electron microscopy analysis of human ACE2 (hACE2), or mouse ACE2 (mACE2), in complex with the RBD of MASCp36, at 3.1 to 3.7 Å resolution, reveals the molecular basis for the receptor-binding switch. N501Y and Q493H enhance the binding affinity to hACE2, whereas triple mutations at N501Y/Q493H/K417N decrease affinity and reduce infectivity of MASCp36. Our study provides a platform for studying SARS-CoV-2 pathogenesis, and unveils the molecular mechanism for its rapid adaptation and evolution.
UR - https://www.scopus.com/pages/publications/85115773072
U2 - 10.1038/s41467-021-25903-x
DO - 10.1038/s41467-021-25903-x
M3 - Article
C2 - 34580297
AN - SCOPUS:85115773072
SN - 2041-1723
VL - 12
JO - Nature Communications
JF - Nature Communications
IS - 1
M1 - 5654
ER -